Two River

Portfolio · 1

UroGen Pharma

Urologic Oncology Therapies

1 round $18.0M committed Latest: 2015-11

Investment activity

1 portfolio exit on record.

Q&A

What is Two River's primary sector focus for investments?

Two River primarily focuses its investments in the Health Tech & Life Sciences sector, as evidenced by its portfolio company UroGen Pharma.

Can you name a notable exit for Two River?

Two River had a notable exit with UroGen Pharma, which went public on NASDAQ in May 2017 with a valuation of $155.6M.

What is the funding stage Two River typically invests in?

Two River has participated in A Round funding stages, as seen with its investment in UroGen Pharma in November 2015.

What is the total capital raised by UroGen Pharma, a Two River portfolio company, prior to its IPO?

UroGen Pharma, a Two River portfolio company, raised $58.2M in capital prior to its IPO in May 2017.

When did Two River make its investment in UroGen Pharma?

Two River made an investment in UroGen Pharma in November 2015.